Company Filing History:
Years Active: 2011-2012
Title: Amrita Agnes Bobok: Innovator in mGluR Compounds
Introduction
Amrita Agnes Bobok is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate mGluR receptors. With a total of 2 patents, her work is paving the way for advancements in therapeutic treatments.
Latest Patents
Amrita's latest patents include innovative compounds that target mGluR activity. The first patent, titled "Thieno [2,3-b] pyridine compounds with mGluR activity," provides a detailed description of these compounds, their preparation processes, and their potential applications in treating conditions requiring modulation of mGluR1 and mGluR5 receptors. The second patent focuses on "Sulfonyl-quinoline derivatives," which are new ligands preferring mGluR1 and mGluR5 receptor subtypes. This invention also outlines the processes for their preparation and their pharmaceutical applications.
Career Highlights
Amrita is currently employed at Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. Her role involves extensive research and development in the field of medicinal chemistry, where she applies her expertise to create innovative solutions for healthcare challenges.
Collaborations
Throughout her career, Amrita has collaborated with talented individuals such as Monika Vastag and Janos Galambos. These partnerships have fostered a creative environment that enhances the development of groundbreaking pharmaceutical compounds.
Conclusion
Amrita Agnes Bobok is a distinguished inventor whose work in mGluR compounds is making a significant impact in the pharmaceutical industry. Her contributions are essential for the advancement of treatments that address critical health conditions.